Document is current

Any future updates will be listed below

Obinutuzumab as a viable therapeutic strategy in rituximab-refractory childhood frequently relapsing, steroid-dependent nephrotic syndrome that relapsed during B-cell depletion

Crossref DOI link: https://doi.org/10.1007/s00467-024-06570-8

Published Online: 2024-10-28

Published Print: 2025-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark